USA Animal Model Market

USA Animal Model Market Outlook (2023 to 2033)

The USA animal model market valuation reached around USD 947.3 million back in 2022. The demand in the USA animal model is set to increase at a 4.3% CAGR from 2023 to 2033. The demand for animal models in the United States, in terms of value, is anticipated to reach USD 1,487.9 million by 2033. According to a study by Future Market Insights, mice held a substantial share of over 61.03% in 2022 within the USA market.

Data Points	Market Insights
USA Animal Model Market Value (2022)	USD 947.3 million
USA Animal Model Market Estimated Value (2023)	USD 976.1 million
USA Animal Model Market Projected Value (2033)	USD 1,487.9 million
USA Animal Model Market Value-based CAGR (2023 to 2033)	4.3%

The animal model plays a valuable role in clinical research for the development of new drugs and treatments. Almost 90% of the processes for the development of drugs are depended on the testing of animal models.

Noticeable similarities, such as anatomical and physiological similarities, in humans and animals make animal models essential for biological research and drug development. Furthermore, the growing need for novel drugs and customized medicines might boost the demand for animal

The rising trend of genetically modified animal models, such as genetically engineered mice for the study of genetic diseases, multifactorial and polygenic (complex) disorders, neurodegenerative diseases, and inflammatory diseases, is boosting the growth in the market. In 2021, the USA animal model held nearly 60% of the global animal model market worth USD 1.5 billion.

Sales Analysis of USA Animal Model from 2017 to 2022 vs. Market Outlook for 2023 to 2033

Demand in the USA animal model market increased at a 3% CAGR between 2017 and 2022. Sales are projected to expand at a 4.3% CAGR over the forecast period due to the growing demand for animal models for regenerative medicine and tissue engineering.

The presence and dominance of CROs in the country, which involve animal models in their research, and increasing focus on personalized medications are key factors expected to drive demand in the USA.

Due to the advent of COVID-19, people gave priority to being fully vaccinated. The demand for clinical research and studies increased with increasing vaccination rates and rising awareness. This directly impacted the demand for animal models as it is used in the development of various vaccines.

Ongoing research and development in the healthcare sector for the development of regenerative medicine and tissue engineering are propelling demand for an animal model. Growing usage of animal model-based preclinical interpretation of new therapeutics and drug discovery & development might fuel sales in the market.

What are the Key Opportunities for USA Animal Model Manufacturers?

Animal models are effective tools for conducting preclinical; studies to learn about human biology. Factors driving the development and usage of animal models are:

• The need to understand how drugs work in humans.
• Growing interest in investigating human-specific diseases, therapies, and immune responses.

The increasing prevalence of diseases is compelling the government to focus on preventive measures. This is driving investments for performing clinical trials on animal models. For instance, in March 2020, the FDA spent around USD 250,000 on testing coronavirus on animal models including monkeys, mice, ferrets, and others.

Hefty investments and policy reforms by the government have stimulated funding schemes with regard to animal model research, which is creating opportunities for growth in the market. In addition to this, different species of animal models have different anatomy, physiology, lifespan, and disease characteristics. Therefore, some experiments on animals do not provide conclusive information on patient outcomes. For accurate clinical research in the discovery of drugs, there is still a need for perfect genetically modified animal models.

Animal model providers are benefitting from the next-generation sequencing technology and genome engineering tools. They provide custom and rare disease models, with a focus on supporting personalized therapy drug trials. For instance,

Charles River Laboratories provides hACE2-NCG mouse models specifically designed for COVID-19 research. Such developments are expected to bode well for the market over the forecast period.

What are the Factors Restraining Demand in the USA Animal Model Market?

Delays in drug approvals and reduced possibilities of medication for human use can hamper the growth of the animal model market. Drugs that survive clinical trials and get approved are sometimes recalled because of toxicity identified in them after a few months or years.

Some animal models have a limited ability to mimic proper complex processes of human physiology, progression, and carcinogenesis. Due to this, safety and efficacy identified in animal studies sometimes cannot be considered for humans. In many cases, certain mouse models’ physiological changes occur in the spectrum that does not occur in human disease.

Some animal model tests take months or years to conduct and analyze. For example, around 4-5 years are taken for rodent cancer studies, which involves thousands and sometimes millions of dollars.

Government regulatory agencies and scientific organizations are finding alternative methods due to the high costs of animal model clinical trials. It is to replace animal testing and provide improvements in the safety of new medications for human use. This can hamper the growth of the animal model market.

Category-wise Insights

Which Species is Driving Sales?

Demand in the Mice Model Segment to Retain their Dominance and Gain Momentum

In terms of species, the mice model segment held a market share of around 61.03% in 2022, with sales anticipated to expand at 5.1% through 2033.

Mice models are one of the most important tools for performing preclinical research to acquire insights into human biology as they are genetically similar to humans. These models are created by engrafting human cells or tissues into mice, resulting in the expression of human proteins.

Mice are increasingly being employed as models in biomedical research for HIV/AIDS, cancer, regenerative medicine, hepatitis, and infectious disease research. They are being developed and used in response to a growing need to determine the true effects of medications on humans. Besides this, the increasing focus on researching human-specific infections, therapies, and immunological responses might continue pushing sales in this segment in the forthcoming years.

Category	By Species
Top Segment	Mice
Market Share in Percentage	61.03%

Category	By End-user Verticals
Top Segment	Academic & Research Institutes
Market Share in Percentage	37.21%

Which is the Leading Therapeutics Segment in the Animal Model Market?

Sales of Animal Models for Oncology Research to Remain High

Based on therapeutics, the oncology segment held nearly 32.6% of the total market share in 2022, and the trend is expected to continue over the forecast period.

Animal models are widely used in oncology to study the biochemical and physiological processes of the occurrence and development of cancer. They help in determining the appropriate treatment approach for specific cancers.

Presently, there is a huge global burden of chronic diseases, including cancer. In vitro as well as in vivo approaches are being developed to fight against the rising prevalence of cancer. One of the most significant advancements is the development of humanized mouse and rodent models. They offer high prescient power for the viability of standard and novel anti-cancer therapeutics.

Factors such as the importance of personalized medicine, monoclonal antibodies, and the potential to treat diseases easily on a personal level are expected to fuel sales in this segment.

Which Application Holds a Dominant Share in the USA Animal Model Market?

Adoption of Animal Models in Novel Drug Discovery to Increase Further

By application, total sales of animal models in the drug discovery/development segment accounted for 65.4% of the total market share in 2022.

Drug discovery/development is invariably a lengthy and costly process. It begins with the identification and validation of a potential molecular/cellular therapeutic target. It further moves through a series of preclinical and clinical trials, culminating in a series of regulatory approvals. The usage of experimental animal models helps researchers better understand the genesis, pathophysiology, and overall character of human diseases.

Animal models for drug discovery and development have played a crucial role in the characterization of disease pathophysiology and associated mechanisms of injury and target identification. They are also used for the evaluation of novel therapeutic agents for toxicity/safety, pharmacodynamics, and pharmacokinetics. They are also used for the efficacy of the development of safe and effective therapies and cures for diseases and/or symptoms connected with them.

Which End User Benefits the Most from the Employment of Animal Model?

Applications of Animal Models in Academic and Research Institutes might Gain Traction

Based on end users, demand in the academic & research institutes segments was about 37.21% of the total market share in 2022. Growth of this segment can be attributed to the increasing establishment of academic & research institutes for developing drugs and vaccines for various chronic diseases.

Researchers utilize animal models to examine and assemble evidence-based findings to address different health-related problems. The availability of highly qualified and skilled scientists at academic & research institutes might also contribute to the growth of this segment.

Competitive Landscape

The USA animal model market is fragmented with the presence of established as well emerging market players. These players are actively investing in acquisitions, collaborations, and product launches as key strategies. For instance:

• In January 2022, Taconic Biosciences launched huNOG-EXL EA (Early Access) humanized immune system mice. This unique mouse model supports human myeloid and lymphoid cells, which makes this mouse model useful for immunological and oncological research.
• In April 2021, Ingenious Targeting Laboratory and SMOC collaborated to produce and distribute catalogue mouse models for Ingenious Targeting Laboratory to distribute SMOC’s validated off-the-shelf mouse models in North America and Europe.
• In June 2021, the Dana-Farber Cancer Institute and Harbour BioMed collaborated to work on novel biotherapies for cancer treatment. Both organizations worked together on the development of CAR-T cell products and bio-specific antibodies.

Report Scope as per USA Animal Model Industry Analysis

Attribute	Details
Forecast Period	2023 to 2033
Historical Data Available for	2017 to 2022
Market Analysis	USD million or billion for Value
Key Countries Covered	The United States of America
Key Market Segments Covered	By Species, By Technology, By Applications, By Use and By End-user Verticals
Key Companies Profiled	Charles River Laboratories; The Jackson Laboratory; Taconic Biosciences, Inc.; Genoway; Envigo (Inotiv, Inc.); Marshall BioResources; Janvier Labs; Applied stem cells; Biocytogen; Transposagen Biopharmaceuticals, Inc. (Hera Bio Labs); Cyagen; Ingenious targeting labs; Crown Bioscience Inc. (JSR Corporation).; Harbour Biomed; Sinclair BioResources; Alpha Genesis Inc.; Creative Animodel; DaVinci Biomedical Research Products, Inc
Report Coverage	Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing	Available upon Request

Table of Content

• 1. Executive Summary
• 2. Market Overview
• 3. Market Background
• 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
• 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Species
  • 5.1. Mouse
  • 5.2. Rat
  • 5.3. Zebrafish
  • 5.4. Rabbit
  • 5.5. Guinea pig
  • 5.6. Others
• 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Therapeutics
  • 6.1. Oncology
  • 6.2. Cardiovascular diseases
  • 6.3. Neurological disorders
  • 6.4. Immunological disorders
  • 6.5. Genetic disorders
  • 6.6. Others
• 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Applications
  • 7.1. Drug discovery and development
  • 7.2. Basic research
  • 7.3. Toxicology
  • 7.4. Preclinical testing
  • 7.5. Others
• 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-users
  • 8.1. Pharmaceutical and biotechnology companies
  • 8.2. Academic and research institutes
  • 8.3. Contract research organizations (CROs)
  • 8.4. Government and regulatory agencies
• 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
  • 9.1. North America
  • 9.2. Latin America
  • 9.3. Europe
  • 9.4. Asia Pacific
  • 9.5. MEA
• 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 13. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
• 15. Key Countries Market Analysis
• 16. Market Structure Analysis
• 17. Competition Analysis
  • 17.1. Charles River Laboratories
  • 17.2. The Jackson Laboratory
  • 17.3. Taconic Biosciences, Inc.
  • 17.4. Genoway
  • 17.5. Envigo (Inotiv, Inc.)
  • 17.6. Marshall BioResources
  • 17.7. Janvier Labs
  • 17.8. Applied Stem Cells
  • 17.9. Biocytogen
  • 17.10. Transposagen Biopharmaceuticals, Inc. (Hera Bio Labs)
  • 17.11. Cyagen
  • 17.12. Ingenious Targeting Labs
  • 17.13. Crown Bioscience Inc. (JSR Corporation)
  • 17.14. Harbour Biomed
  • 17.15. Sinclair BioResources
• 18. Assumptions & Acronyms Used
• 19. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Market Volume (Units) Forecast by Region, 2018 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Species, 2018 to 2033

Table 4: Global Market Volume (Units) Forecast by Species, 2018 to 2033

Table 5: Global Market Value (US$ Million) Forecast by Therapeutics, 2018 to 2033

Table 6: Global Market Volume (Units) Forecast by Therapeutics, 2018 to 2033

Table 7: Global Market Value (US$ Million) Forecast by Applications, 2018 to 2033

Table 8: Global Market Volume (Units) Forecast by Applications, 2018 to 2033

Table 9: Global Market Value (US$ Million) Forecast by End-users, 2018 to 2033

Table 10: Global Market Volume (Units) Forecast by End-users, 2018 to 2033

Table 11: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 12: North America Market Volume (Units) Forecast by Country, 2018 to 2033

Table 13: North America Market Value (US$ Million) Forecast by Species, 2018 to 2033

Table 14: North America Market Volume (Units) Forecast by Species, 2018 to 2033

Table 15: North America Market Value (US$ Million) Forecast by Therapeutics, 2018 to 2033

Table 16: North America Market Volume (Units) Forecast by Therapeutics, 2018 to 2033

Table 17: North America Market Value (US$ Million) Forecast by Applications, 2018 to 2033

Table 18: North America Market Volume (Units) Forecast by Applications, 2018 to 2033

Table 19: North America Market Value (US$ Million) Forecast by End-users, 2018 to 2033

Table 20: North America Market Volume (Units) Forecast by End-users, 2018 to 2033

Table 21: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 22: Latin America Market Volume (Units) Forecast by Country, 2018 to 2033

Table 23: Latin America Market Value (US$ Million) Forecast by Species, 2018 to 2033

Table 24: Latin America Market Volume (Units) Forecast by Species, 2018 to 2033

Table 25: Latin America Market Value (US$ Million) Forecast by Therapeutics, 2018 to 2033

Table 26: Latin America Market Volume (Units) Forecast by Therapeutics, 2018 to 2033

Table 27: Latin America Market Value (US$ Million) Forecast by Applications, 2018 to 2033

Table 28: Latin America Market Volume (Units) Forecast by Applications, 2018 to 2033

Table 29: Latin America Market Value (US$ Million) Forecast by End-users, 2018 to 2033

Table 30: Latin America Market Volume (Units) Forecast by End-users, 2018 to 2033

Table 31: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 32: Europe Market Volume (Units) Forecast by Country, 2018 to 2033

Table 33: Europe Market Value (US$ Million) Forecast by Species, 2018 to 2033

Table 34: Europe Market Volume (Units) Forecast by Species, 2018 to 2033

Table 35: Europe Market Value (US$ Million) Forecast by Therapeutics, 2018 to 2033

Table 36: Europe Market Volume (Units) Forecast by Therapeutics, 2018 to 2033

Table 37: Europe Market Value (US$ Million) Forecast by Applications, 2018 to 2033

Table 38: Europe Market Volume (Units) Forecast by Applications, 2018 to 2033

Table 39: Europe Market Value (US$ Million) Forecast by End-users, 2018 to 2033

Table 40: Europe Market Volume (Units) Forecast by End-users, 2018 to 2033

Table 41: Asia Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 42: Asia Pacific Market Volume (Units) Forecast by Country, 2018 to 2033

Table 43: Asia Pacific Market Value (US$ Million) Forecast by Species, 2018 to 2033

Table 44: Asia Pacific Market Volume (Units) Forecast by Species, 2018 to 2033

Table 45: Asia Pacific Market Value (US$ Million) Forecast by Therapeutics, 2018 to 2033

Table 46: Asia Pacific Market Volume (Units) Forecast by Therapeutics, 2018 to 2033

Table 47: Asia Pacific Market Value (US$ Million) Forecast by Applications, 2018 to 2033

Table 48: Asia Pacific Market Volume (Units) Forecast by Applications, 2018 to 2033

Table 49: Asia Pacific Market Value (US$ Million) Forecast by End-users, 2018 to 2033

Table 50: Asia Pacific Market Volume (Units) Forecast by End-users, 2018 to 2033

Table 51: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 52: MEA Market Volume (Units) Forecast by Country, 2018 to 2033

Table 53: MEA Market Value (US$ Million) Forecast by Species, 2018 to 2033

Table 54: MEA Market Volume (Units) Forecast by Species, 2018 to 2033

Table 55: MEA Market Value (US$ Million) Forecast by Therapeutics, 2018 to 2033

Table 56: MEA Market Volume (Units) Forecast by Therapeutics, 2018 to 2033

Table 57: MEA Market Value (US$ Million) Forecast by Applications, 2018 to 2033

Table 58: MEA Market Volume (Units) Forecast by Applications, 2018 to 2033

Table 59: MEA Market Value (US$ Million) Forecast by End-users, 2018 to 2033

Table 60: MEA Market Volume (Units) Forecast by End-users, 2018 to 2033

List of Figures

Figure 1: Global Market Value (US$ Million) by Species, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Therapeutics, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by Applications, 2023 to 2033

Figure 4: Global Market Value (US$ Million) by End-users, 2023 to 2033

Figure 5: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 6: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 7: Global Market Volume (Units) Analysis by Region, 2018 to 2033

Figure 8: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 9: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 10: Global Market Value (US$ Million) Analysis by Species, 2018 to 2033

Figure 11: Global Market Volume (Units) Analysis by Species, 2018 to 2033

Figure 12: Global Market Value Share (%) and BPS Analysis by Species, 2023 to 2033

Figure 13: Global Market Y-o-Y Growth (%) Projections by Species, 2023 to 2033

Figure 14: Global Market Value (US$ Million) Analysis by Therapeutics, 2018 to 2033

Figure 15: Global Market Volume (Units) Analysis by Therapeutics, 2018 to 2033

Figure 16: Global Market Value Share (%) and BPS Analysis by Therapeutics, 2023 to 2033

Figure 17: Global Market Y-o-Y Growth (%) Projections by Therapeutics, 2023 to 2033

Figure 18: Global Market Value (US$ Million) Analysis by Applications, 2018 to 2033

Figure 19: Global Market Volume (Units) Analysis by Applications, 2018 to 2033

Figure 20: Global Market Value Share (%) and BPS Analysis by Applications, 2023 to 2033

Figure 21: Global Market Y-o-Y Growth (%) Projections by Applications, 2023 to 2033

Figure 22: Global Market Value (US$ Million) Analysis by End-users, 2018 to 2033

Figure 23: Global Market Volume (Units) Analysis by End-users, 2018 to 2033

Figure 24: Global Market Value Share (%) and BPS Analysis by End-users, 2023 to 2033

Figure 25: Global Market Y-o-Y Growth (%) Projections by End-users, 2023 to 2033

Figure 26: Global Market Attractiveness by Species, 2023 to 2033

Figure 27: Global Market Attractiveness by Therapeutics, 2023 to 2033

Figure 28: Global Market Attractiveness by Applications, 2023 to 2033

Figure 29: Global Market Attractiveness by End-users, 2023 to 2033

Figure 30: Global Market Attractiveness by Region, 2023 to 2033

Figure 31: North America Market Value (US$ Million) by Species, 2023 to 2033

Figure 32: North America Market Value (US$ Million) by Therapeutics, 2023 to 2033

Figure 33: North America Market Value (US$ Million) by Applications, 2023 to 2033

Figure 34: North America Market Value (US$ Million) by End-users, 2023 to 2033

Figure 35: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 36: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 37: North America Market Volume (Units) Analysis by Country, 2018 to 2033

Figure 38: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 39: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 40: North America Market Value (US$ Million) Analysis by Species, 2018 to 2033

Figure 41: North America Market Volume (Units) Analysis by Species, 2018 to 2033

Figure 42: North America Market Value Share (%) and BPS Analysis by Species, 2023 to 2033

Figure 43: North America Market Y-o-Y Growth (%) Projections by Species, 2023 to 2033

Figure 44: North America Market Value (US$ Million) Analysis by Therapeutics, 2018 to 2033

Figure 45: North America Market Volume (Units) Analysis by Therapeutics, 2018 to 2033

Figure 46: North America Market Value Share (%) and BPS Analysis by Therapeutics, 2023 to 2033

Figure 47: North America Market Y-o-Y Growth (%) Projections by Therapeutics, 2023 to 2033

Figure 48: North America Market Value (US$ Million) Analysis by Applications, 2018 to 2033

Figure 49: North America Market Volume (Units) Analysis by Applications, 2018 to 2033

Figure 50: North America Market Value Share (%) and BPS Analysis by Applications, 2023 to 2033

Figure 51: North America Market Y-o-Y Growth (%) Projections by Applications, 2023 to 2033

Figure 52: North America Market Value (US$ Million) Analysis by End-users, 2018 to 2033

Figure 53: North America Market Volume (Units) Analysis by End-users, 2018 to 2033

Figure 54: North America Market Value Share (%) and BPS Analysis by End-users, 2023 to 2033

Figure 55: North America Market Y-o-Y Growth (%) Projections by End-users, 2023 to 2033

Figure 56: North America Market Attractiveness by Species, 2023 to 2033

Figure 57: North America Market Attractiveness by Therapeutics, 2023 to 2033

Figure 58: North America Market Attractiveness by Applications, 2023 to 2033

Figure 59: North America Market Attractiveness by End-users, 2023 to 2033

Figure 60: North America Market Attractiveness by Country, 2023 to 2033

Figure 61: Latin America Market Value (US$ Million) by Species, 2023 to 2033

Figure 62: Latin America Market Value (US$ Million) by Therapeutics, 2023 to 2033

Figure 63: Latin America Market Value (US$ Million) by Applications, 2023 to 2033

Figure 64: Latin America Market Value (US$ Million) by End-users, 2023 to 2033

Figure 65: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 66: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 67: Latin America Market Volume (Units) Analysis by Country, 2018 to 2033

Figure 68: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 69: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 70: Latin America Market Value (US$ Million) Analysis by Species, 2018 to 2033

Figure 71: Latin America Market Volume (Units) Analysis by Species, 2018 to 2033

Figure 72: Latin America Market Value Share (%) and BPS Analysis by Species, 2023 to 2033

Figure 73: Latin America Market Y-o-Y Growth (%) Projections by Species, 2023 to 2033

Figure 74: Latin America Market Value (US$ Million) Analysis by Therapeutics, 2018 to 2033

Figure 75: Latin America Market Volume (Units) Analysis by Therapeutics, 2018 to 2033

Figure 76: Latin America Market Value Share (%) and BPS Analysis by Therapeutics, 2023 to 2033

Figure 77: Latin America Market Y-o-Y Growth (%) Projections by Therapeutics, 2023 to 2033

Figure 78: Latin America Market Value (US$ Million) Analysis by Applications, 2018 to 2033

Figure 79: Latin America Market Volume (Units) Analysis by Applications, 2018 to 2033

Figure 80: Latin America Market Value Share (%) and BPS Analysis by Applications, 2023 to 2033

Figure 81: Latin America Market Y-o-Y Growth (%) Projections by Applications, 2023 to 2033

Figure 82: Latin America Market Value (US$ Million) Analysis by End-users, 2018 to 2033

Figure 83: Latin America Market Volume (Units) Analysis by End-users, 2018 to 2033

Figure 84: Latin America Market Value Share (%) and BPS Analysis by End-users, 2023 to 2033

Figure 85: Latin America Market Y-o-Y Growth (%) Projections by End-users, 2023 to 2033

Figure 86: Latin America Market Attractiveness by Species, 2023 to 2033

Figure 87: Latin America Market Attractiveness by Therapeutics, 2023 to 2033

Figure 88: Latin America Market Attractiveness by Applications, 2023 to 2033

Figure 89: Latin America Market Attractiveness by End-users, 2023 to 2033

Figure 90: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 91: Europe Market Value (US$ Million) by Species, 2023 to 2033

Figure 92: Europe Market Value (US$ Million) by Therapeutics, 2023 to 2033

Figure 93: Europe Market Value (US$ Million) by Applications, 2023 to 2033

Figure 94: Europe Market Value (US$ Million) by End-users, 2023 to 2033

Figure 95: Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 96: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 97: Europe Market Volume (Units) Analysis by Country, 2018 to 2033

Figure 98: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 99: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 100: Europe Market Value (US$ Million) Analysis by Species, 2018 to 2033

Figure 101: Europe Market Volume (Units) Analysis by Species, 2018 to 2033

Figure 102: Europe Market Value Share (%) and BPS Analysis by Species, 2023 to 2033

Figure 103: Europe Market Y-o-Y Growth (%) Projections by Species, 2023 to 2033

Figure 104: Europe Market Value (US$ Million) Analysis by Therapeutics, 2018 to 2033

Figure 105: Europe Market Volume (Units) Analysis by Therapeutics, 2018 to 2033

Figure 106: Europe Market Value Share (%) and BPS Analysis by Therapeutics, 2023 to 2033

Figure 107: Europe Market Y-o-Y Growth (%) Projections by Therapeutics, 2023 to 2033

Figure 108: Europe Market Value (US$ Million) Analysis by Applications, 2018 to 2033

Figure 109: Europe Market Volume (Units) Analysis by Applications, 2018 to 2033

Figure 110: Europe Market Value Share (%) and BPS Analysis by Applications, 2023 to 2033

Figure 111: Europe Market Y-o-Y Growth (%) Projections by Applications, 2023 to 2033

Figure 112: Europe Market Value (US$ Million) Analysis by End-users, 2018 to 2033

Figure 113: Europe Market Volume (Units) Analysis by End-users, 2018 to 2033

Figure 114: Europe Market Value Share (%) and BPS Analysis by End-users, 2023 to 2033

Figure 115: Europe Market Y-o-Y Growth (%) Projections by End-users, 2023 to 2033

Figure 116: Europe Market Attractiveness by Species, 2023 to 2033

Figure 117: Europe Market Attractiveness by Therapeutics, 2023 to 2033

Figure 118: Europe Market Attractiveness by Applications, 2023 to 2033

Figure 119: Europe Market Attractiveness by End-users, 2023 to 2033

Figure 120: Europe Market Attractiveness by Country, 2023 to 2033

Figure 121: Asia Pacific Market Value (US$ Million) by Species, 2023 to 2033

Figure 122: Asia Pacific Market Value (US$ Million) by Therapeutics, 2023 to 2033

Figure 123: Asia Pacific Market Value (US$ Million) by Applications, 2023 to 2033

Figure 124: Asia Pacific Market Value (US$ Million) by End-users, 2023 to 2033

Figure 125: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033

Figure 126: Asia Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 127: Asia Pacific Market Volume (Units) Analysis by Country, 2018 to 2033

Figure 128: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 129: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 130: Asia Pacific Market Value (US$ Million) Analysis by Species, 2018 to 2033

Figure 131: Asia Pacific Market Volume (Units) Analysis by Species, 2018 to 2033

Figure 132: Asia Pacific Market Value Share (%) and BPS Analysis by Species, 2023 to 2033

Figure 133: Asia Pacific Market Y-o-Y Growth (%) Projections by Species, 2023 to 2033

Figure 134: Asia Pacific Market Value (US$ Million) Analysis by Therapeutics, 2018 to 2033

Figure 135: Asia Pacific Market Volume (Units) Analysis by Therapeutics, 2018 to 2033

Figure 136: Asia Pacific Market Value Share (%) and BPS Analysis by Therapeutics, 2023 to 2033

Figure 137: Asia Pacific Market Y-o-Y Growth (%) Projections by Therapeutics, 2023 to 2033

Figure 138: Asia Pacific Market Value (US$ Million) Analysis by Applications, 2018 to 2033

Figure 139: Asia Pacific Market Volume (Units) Analysis by Applications, 2018 to 2033

Figure 140: Asia Pacific Market Value Share (%) and BPS Analysis by Applications, 2023 to 2033

Figure 141: Asia Pacific Market Y-o-Y Growth (%) Projections by Applications, 2023 to 2033

Figure 142: Asia Pacific Market Value (US$ Million) Analysis by End-users, 2018 to 2033

Figure 143: Asia Pacific Market Volume (Units) Analysis by End-users, 2018 to 2033

Figure 144: Asia Pacific Market Value Share (%) and BPS Analysis by End-users, 2023 to 2033

Figure 145: Asia Pacific Market Y-o-Y Growth (%) Projections by End-users, 2023 to 2033

Figure 146: Asia Pacific Market Attractiveness by Species, 2023 to 2033

Figure 147: Asia Pacific Market Attractiveness by Therapeutics, 2023 to 2033

Figure 148: Asia Pacific Market Attractiveness by Applications, 2023 to 2033

Figure 149: Asia Pacific Market Attractiveness by End-users, 2023 to 2033

Figure 150: Asia Pacific Market Attractiveness by Country, 2023 to 2033

Figure 151: MEA Market Value (US$ Million) by Species, 2023 to 2033

Figure 152: MEA Market Value (US$ Million) by Therapeutics, 2023 to 2033

Figure 153: MEA Market Value (US$ Million) by Applications, 2023 to 2033

Figure 154: MEA Market Value (US$ Million) by End-users, 2023 to 2033

Figure 155: MEA Market Value (US$ Million) by Country, 2023 to 2033

Figure 156: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 157: MEA Market Volume (Units) Analysis by Country, 2018 to 2033

Figure 158: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 159: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 160: MEA Market Value (US$ Million) Analysis by Species, 2018 to 2033

Figure 161: MEA Market Volume (Units) Analysis by Species, 2018 to 2033

Figure 162: MEA Market Value Share (%) and BPS Analysis by Species, 2023 to 2033

Figure 163: MEA Market Y-o-Y Growth (%) Projections by Species, 2023 to 2033

Figure 164: MEA Market Value (US$ Million) Analysis by Therapeutics, 2018 to 2033

Figure 165: MEA Market Volume (Units) Analysis by Therapeutics, 2018 to 2033

Figure 166: MEA Market Value Share (%) and BPS Analysis by Therapeutics, 2023 to 2033

Figure 167: MEA Market Y-o-Y Growth (%) Projections by Therapeutics, 2023 to 2033

Figure 168: MEA Market Value (US$ Million) Analysis by Applications, 2018 to 2033

Figure 169: MEA Market Volume (Units) Analysis by Applications, 2018 to 2033

Figure 170: MEA Market Value Share (%) and BPS Analysis by Applications, 2023 to 2033

Figure 171: MEA Market Y-o-Y Growth (%) Projections by Applications, 2023 to 2033

Figure 172: MEA Market Value (US$ Million) Analysis by End-users, 2018 to 2033

Figure 173: MEA Market Volume (Units) Analysis by End-users, 2018 to 2033

Figure 174: MEA Market Value Share (%) and BPS Analysis by End-users, 2023 to 2033

Figure 175: MEA Market Y-o-Y Growth (%) Projections by End-users, 2023 to 2033

Figure 176: MEA Market Attractiveness by Species, 2023 to 2033

Figure 177: MEA Market Attractiveness by Therapeutics, 2023 to 2033

Figure 178: MEA Market Attractiveness by Applications, 2023 to 2033

Figure 179: MEA Market Attractiveness by End-users, 2023 to 2033

Figure 180: MEA Market Attractiveness by Country, 2023 to 2033